Head and Neck Squamous Cell Carcinoma Market Share

North American Market Forecast

The North American head and neck squamous cell carcinoma (HNSCC) market, amongst the market in all the other regions, is projected to hold the largest market share of about 52% by the end of 2037. The growth of the market can be attributed majorly to the increasing frequency of head and neck cancer backed by the surging ratio of alcohol, and tobacco consumption in people in the region. For instance, around 56,000 cases of oral and pharyngeal cancer are diagnosed in the United States each year, leading to over 12,000 deaths each year. Moreover, owing to the presence of a strong healthcare network, and the availability of numerous key players in the region, the market for head and neck squamous cell carcinoma (HNSCC) treatment and drugs is anticipated to display significant growth in the North American region. In addition to this, high awareness among people regarding the disease, along with the presence of favorable reimbursement policies and the availability of quality medical facilities are some more factors anticipated to boost the market growth further throughout the forecast period in the region.

APAC Market Statistics

The Asia Pacific head and neck squamous cell carcinoma (HNSCC) market, amongst the market in all the other regions, is projected to hold the second largest share of about 29% during the forecast period. The growth of the market can be attributed majorly to the surging population, coupled with the significant increase in the geriatric population, the growing prevalence of smoking, and escalating consumption of alcohol among people in the region. For instance, in 2020, the predicted frequency of any tobacco product consumption among men was around 41% in Malaysia, 38% in Thailand, 47% in South Korea, 30% in Singapore, 15% in Australia, and 10% in Hong Kong. In addition, the escalating prescription of immunotherapy drugs for the effective treatment of several kinds of head and neck cancer is also anticipated to boost the market growth during the forecast period.

Europe Market Forecast

Further, the market in the European region, amongst the market in all the other regions, is projected to hold a considerable share of about 10% by the end of 2037. The growth of the market can be attributed majorly to the surging ratio of head and neck cancer among people especially men in the region. Moreover, the escalating consumption of alcohol among youngsters is also projected to spike the market growth in the region in the coming years. In addition to this, the usage of tobacco and tobacco products by a large pool of the European population has increased in recent years. For instance, in 2021, almost 188 million people, or 28% of the adult population of Europe, were tobacco users. This, as a result, is also estimated to boost the market growth further during the forecast period in the region.